A Cross-Sectional Study to Evaluate the Effects of Age and Duration of HIV Infection on Anxiety and Depression in Cisgender Men
- PMID: 34287757
- PMCID: PMC8294268
- DOI: 10.1007/s10461-021-03373-y
A Cross-Sectional Study to Evaluate the Effects of Age and Duration of HIV Infection on Anxiety and Depression in Cisgender Men
Erratum in
-
Correction to: A Cross‑Sectional Study to Evaluate the Effects of Age and Duration of HIV Infection on Anxiety and Depression in Cisgender Men.AIDS Behav. 2022 Jan;26(1):204. doi: 10.1007/s10461-021-03421-7. AIDS Behav. 2022. PMID: 34427814 Free PMC article. No abstract available.
Abstract
This observational cross-sectional study of 152 people with HIV (PWH) examined the effects of age and estimated duration of HIV infection (EDI) on depressive and anxiety symptoms. All participants were cisgender men and completed the Profile of Moods State (POMS), a self-report inventory of current (i.e., past week) mood states. Overall, study results confirmed higher levels of anxiety and depression in PWH compared to individuals without HIV. Age group (< 50 or ≥ 50 years) moderated the effect of EDI (< 3 or ≥ 3 years) on mood disturbance. Specifically, younger PWH with early diagnosed infection exhibited the highest levels of depression and anxiety, whereas depression and anxiety were attenuated in older PWH with early infection such that their POMS scores did not significantly differ from the HIV-negative and chronically HIV-infected groups. Despite the small sample size and other important limitations in our study design, our preliminary findings confirm previous observations that older people may have some adaptive ability to better handle the acute psychological stressors associated with recent HIV infection.
Keywords: Anxiety; Depression; Duration of HIV infection; HIV.
© 2021. The Author(s).
Conflict of interest statement
The authors have no Conflict of Interest to Report.
Figures

Similar articles
-
Neuropsychiatric predictors of cognitive functioning over a one-year follow-up period in HIV.J Affect Disord. 2023 Sep 1;336:92-96. doi: 10.1016/j.jad.2023.05.030. Epub 2023 May 19. J Affect Disord. 2023. PMID: 37211052 Free PMC article.
-
Brain-derived neurotrophic factor (BDNF) is associated with depressive symptoms in older adults with HIV disease.J Neurovirol. 2021 Feb;27(1):70-79. doi: 10.1007/s13365-020-00916-2. Epub 2020 Nov 3. J Neurovirol. 2021. PMID: 33145707
-
Symptomatology and Quality of Life of Older People With HIV and Comorbid Chronic Obstructive Pulmonary Diseases From an HIV Clinic in Birmingham, Alabama.J Assoc Nurses AIDS Care. 2024 Mar-Apr 01;35(2):91-103. doi: 10.1097/JNC.0000000000000452. Epub 2024 Feb 6. J Assoc Nurses AIDS Care. 2024. PMID: 38319887 Free PMC article.
-
[Anhedonia and depressive symptomatology among HIV-infected patients with highly active antiretroviral therapies (ANRS-EN12-VESPA)].Encephale. 2008 Sep;34(4):385-93. doi: 10.1016/j.encep.2007.05.004. Epub 2007 Oct 24. Encephale. 2008. PMID: 18922241 French.
-
The association between depressive symptoms and neurocognitive impairment in people with well-treated HIV in Switzerland.Int J STD AIDS. 2021 Jul;32(8):729-739. doi: 10.1177/0956462420987434. Epub 2021 Feb 25. Int J STD AIDS. 2021. PMID: 33629882
Cited by
-
Family Functioning and Depressive Symptoms Among HIV-Positive Men Who Have Sex with Men: Mediating Roles of Stigma and Resilience.Psychol Res Behav Manag. 2024 Feb 26;17:755-764. doi: 10.2147/PRBM.S449825. eCollection 2024. Psychol Res Behav Manag. 2024. PMID: 38434956 Free PMC article.
-
Neuroinflammation in HIV-associated depression: evidence and future perspectives.Mol Psychiatry. 2022 Sep;27(9):3619-3632. doi: 10.1038/s41380-022-01619-2. Epub 2022 May 26. Mol Psychiatry. 2022. PMID: 35618889 Free PMC article. Review.
-
The effect of emotional freedom techniques on anxiety depression and sleep in older people living with HIV: a randomized controlled trial.AIDS Res Ther. 2024 Dec 20;21(1):94. doi: 10.1186/s12981-024-00679-4. AIDS Res Ther. 2024. PMID: 39707382 Free PMC article. Clinical Trial.
References
-
- WHO-Depression (https://www.who.int/news-room/fact-sheets/detail/depression). 2020. Accessed Jan 2021.
-
- Rabkin JG. HIV and depression: 2008 review and update. Curr HIV/AIDS Rep. 2008;5(4):163–171. - PubMed
-
- Gandhi RT, Spritzler J, Chan E, Asmuth DM, Rodriguez B, Merigan TC, et al. Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384. J Acquir Immune Defic Syndr. 2006;42(4):426–434. - PubMed
Publication types
MeSH terms
Grants and funding
- MH062512/MH/NIMH NIH HHS/United States
- MH099987/AG/NIA NIH HHS/United States
- DA051915/DA/NIDA NIH HHS/United States
- R21 AI134295/AI/NIAID NIH HHS/United States
- F31 AG064989/AG/NIA NIH HHS/United States
- P30 AI036214/AI/NIAID NIH HHS/United States
- R01 MH099987/MH/NIMH NIH HHS/United States
- K23 DA051324/DA/NIDA NIH HHS/United States
- P01 AI131385/AI/NIAID NIH HHS/United States
- R24 AI106039/AI/NIAID NIH HHS/United States
- R01 AI147821/AI/NIAID NIH HHS/United States
- UL1 TR001442/TR/NCATS NIH HHS/United States
- R21 HD094646/HD/NICHD NIH HHS/United States
- DP2 DA051915/DA/NIDA NIH HHS/United States
- P30 AI027763/AI/NIAID NIH HHS/United States
- P30 MH062512/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous